(Total Views: 751)
Posted On: 04/22/2021 10:35:49 AM
Post# of 99

$ONTX News Article - Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma https://marketwirenews.com/news-releases/onco...92860.html


My Twitter: WhyteStocks